(Q33996024)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851472%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

A human neutralizing antibody specific to Ang-2 inhibits ocular angiogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851472%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851472%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

David O. Bates

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851472%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Emma S Rennel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851472%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Steven J Harper

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851472%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Markus Thomas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851472%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Christian Klein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851472%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851472%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851472%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851472%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851472%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

598-607

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851472%20AND%20SRC:MED&resulttype=core&format=json

Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Modes of resistance to anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Angiopoietin-2 plays an important role in retinal angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Recombinant human VEGF165b inhibits experimental choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Targeting the ANGPT-TIE2 pathway in malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

VEGF-A165b is cytoprotective and antiangiogenic in the retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Angiopoietin-2 enhances retinal vessel sensitivity to vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

Current molecular understanding and future treatment strategies for pathologic ocular neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1549-8719.2011.00120.X

10.1111/J.1549-8719.2011.00120.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851472%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference